Conmed Corp (CNMD) Files 10-K for the Fiscal Year Ended on December 31, 2018

Conmed Corp (NASDAQ:CNMD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Conmed Corp is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The Company's products serve the clinical areas, surgeons and physicians. Conmed Corp has a market cap of $2.12 billion; its shares were traded at around $75.53 with a P/E ratio of 53.57 and P/S ratio of 2.57. The dividend yield of Conmed Corp stocks is 1.05%. Conmed Corp had annual average EBITDA growth of 1.50% over the past ten years.

For the last quarter Conmed Corp reported a revenue of $242.4 million, compared with the revenue of $222.6 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $859.6 million, an increase of 7.9% from last year. For the last five years Conmed Corp had an average revenue growth rate of 2.7% a year.

The reported diluted earnings per share was $1.41 for the year, a decline of 28.4% from the previous year. Over the last five years Conmed Corp had an EPS growth rate of 3.9% a year. The Conmed Corp had an operating margin of 8.29%, compared with the operating margin of 5.89% a year before. The 10-year historical median operating margin of Conmed Corp is 7.95%. The profitability rank of the company is 6 (out of 10).

At the current stock price of $75.53, Conmed Corp is traded at 103.2% premium to its historical median P/S valuation band of $37.17. The P/S ratio of the stock is 2.57, while the historical median P/S ratio is 1.27. The stock gained 26.75% during the past 12 months.

Directors and Officers Recent Trades:

EVP, STRAT & CORP DEVT Peter K Shagory sold 4,000 shares of CNMD stock on 01/31/2019 at the average price of $69.29. The price of the stock has increased by 9.01% since.

For the complete 20-year historical financial data of CNMD, click here.